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Introduction. Helium is a noble gas with low density and increased carbon dioxide (CO
2
) diffusion capacity. This allows lower
driving pressures in mechanical ventilation and increased CO
2
diffusion. We hypothesized that heliox facilitates ventilation in
patients during lung-protectivemechanical ventilation using low tidal volumes.Methods.This is an observational cohort substudy of
a single arm intervention study. Twenty-four ICUpatients were included, whowere admitted after a cardiac arrest andmechanically
ventilated for 3 hours with heliox (50% helium; 50% oxygen). A fixed protective ventilation protocol (6mL/kg) was used, with
prospective observation for changes in lung mechanics and gas exchange. Statistics was by Bonferroni post-hoc correction with
statistical significance set at 𝑃 < 0.017. Results. During heliox ventilation, respiratory rate decreased (25 ± 4 versus 23 ± 5
breathsmin−1, 𝑃 = 0.010). Minute volume ventilation showed a trend to decrease compared to baseline (11.1 ± 1.9 versus
9.9 ± 2.1 Lmin−1, 𝑃 = 0.026), while reducing PaCO
2
levels (5.0 ± 0.6 versus 4.5 ± 0.6 kPa, 𝑃 = 0.011) and peak pressures (21.1 ± 3.3
versus 19.8 ± 3.2 cm H
2
O, 𝑃 = 0.024). Conclusions. Heliox improved CO
2
elimination while allowing reduced minute volume
ventilation in adult patients during protective mechanical ventilation.
1. Introduction
Helium is an inert gas with lower density than air [1],
allowing for less turbulent flow through airways and leading
to lower airway resistance. As a result, during mechanical
ventilation with a helium/oxygen mixture (heliox), lower
driving pressures are needed to distribute oxygen to the distal
alveoli compared to ventilationwith oxygen [2]. Furthermore
helium is known for its increased diffusion capacity of carbon
dioxide (CO
2
), which in addition might facilitate ventilation.
Due to these properties, theremay be a rationale to use heliox
in patients with severe pulmonary disease with respiratory
failure whose protectivemechanical ventilationwith low tidal
volumes is not feasible due to the development of respiratory
acidosis, for example, in acute respiratory distress syndrome
(ARDS) or chronic obstructive pulmonary disease (COPD).
Nowadays, the use of heliox is clinically applied using high
frequency ventilation in pediatric patients [3, 4] and in
patients with high airway resistance due to severe asthma
or COPD, most often in children [5, 6]. Clinical data on
adult patients during conventionalmechanical ventilation are
limited.
The aim of this study was to investigate the effect of heliox
on gas exchange as part of a safety and feasibility study on
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the potential of heliox ventilation to improve neurological
outcome after cardiac arrest [7]. We hypothesized that the
use of heliox also allows for increased CO
2
elimination in
adults during conventional mechanical ventilation with low
tidal volumes.
2. Methods
The study was approved by the local medical ethics
committee of the Academic Medical Center, University
of Amsterdam, The Netherlands (Protocol number NL
30466.018.09), and conducted in concordance with the
principles of the declaration of Helsinki and good clinical
practice. The study was registered with the Dutch Trial Reg-
istry (http://www.trialregister.nl) under NTR2257. From all
patients or their legal surrogate written informed consent was
obtained. It was a prospective observational cohort substudy
of an open label single arm intervention study, performed
in the mixed surgical-medical intensive care unit (ICU) of a
tertiary referral center inAmsterdam,TheNetherlands. From
April 2010 to October 2011, consecutive patients admitted to
the ICU after cardiopulmonary resuscitation (CPR) because
of a witnessed out-of-hospital cardiac arrest were screened
for inclusion in the study after informed consent was given
by their relatives. Inclusion criteria were return of sponta-
neous circulation within 30 minutes of arrest and coma on
admission. Exclusion criteria were hypoxemia with a need for
ventilation with a FiO
2
higher than 50% or more than 10 cm
H
2
O positive end-expiratory pressure (PEEP), pregnancy,
severe disability, a neurological disorder, or comorbidity with
life expectancy of less than 6 months.
Before the start of heliox ventilation, all patientswere ven-
tilated in a pressure-controlled mode, targeting a pH of 7.35–
7.45 and PaCO
2
levels of 4.5–5.5 kPa. Within 5 hours after
the cardiac arrest patients received heliox ventilation. During
heliox treatment patients were mechanically ventilated in a
pressure controlled mode, using a Servo-I ventilator, which
was adjusted and calibrated for heliox ventilation. Helium
(Linde Gas Therapeutics, Eindhoven, The Netherlands) was
mixed with oxygen to achieve a concentration of 50% helium
and 50% oxygen. Respiratory settings were modified using
a study protocol. Inspiratory pressure and respiratory rate
were adjusted to target a tidal volume of 6mL/kg predicted
body weight, a pH of 7.35–7.45, and PaCO
2
levels of 4.5–
5.5 kPa, with an inspiration to expiration (I : E) ratio of 1 : 2.
No changes were made to I : E ratio and FiO
2
and PEEP
levels during heliox treatment. After 3 hours, heliox was
switched back to oxygen in air and patients were ventilated
according to our standard ICU protocol with tidal volumes of
6mL/kg predicted bodyweight. All patients were treatedwith
therapeutic hypothermia (32∘C–34∘C) as part of standard
care in patients with decreased consciousness after CPR.
Target temperature had been reached by the time heliox
ventilation was initiated and was maintained during heliox
ventilation. For sedation, propofol and opiates were used.
Neuromuscular relaxants were given as a bolus but only
during shivering.
Respiratory parameters were measured over time, start-
ing just prior to heliox ventilation (𝑇 = −1), within 15minutes
after start heliox (𝑇 = 0), during heliox treatment (𝑇 =
1–𝑇 = 3), and until 3 hours after heliox was switched back
to oxygen in air (𝑇 = 4–𝑇 = 6). After the switch back,
again all patients were ventilated in a pressure-controlled
mode, targeting a pH of 7.35–7.45 and PaCO
2
levels of 4.5–
5.5 kPa. Dynamic lung compliance was measured during
heliox ventilation (𝑇 = 1–𝑇 = 3), as this was a read-out at the
Servo-I ventilator only. Resistance was calculated by dividing
the pressure difference by airflow per minute. Arterial blood
gas analysis was determined hourly (Alpha stat, RAPIDLab
1200, Siemens, Deerfield, USA).
2.1. Statistical Analysis. Data are expressed by means and the
standard error of the mean (SEM) in the figures. Time points
within the same subjects were compared using paired 𝑡-test
or Wilcoxon signed rank test, depending on distribution of
the data. A total of three comparisons were made between
several time points (𝑇 = −1 versus 𝑇 = 0; 𝑇 = 0 versus 𝑇 = 3;
𝑇 = 3 versus 𝑇 = 6). Using Bonferroni post-hoc correction,
statistical significance was set at 𝑃 < 0.017.
3. Results
106 patients were screened, of whom 29 were eligible. Of
these, informed consent was refused in 4 cases. Of 25
included patients, heliox was discontinued within 15 minutes
in one patient due to hypoxemia, requiring a PEEP level above
10 cm H
2
O. This patient was excluded from further analyses.
In the remaining 24 patients, PEEP requirements were 5–
10 cm H
2
O and 40–50% FiO
2
. Of these, 83% were male with
a mean age of 65 ± 12 years; no acute infections were present
at start of the study; 1 patient suffered from COPD; no other
lung pathology was reported. During the study protocol, no
changes in hemodynamics were observed.
Due to the switch of ventilation gas mixture from oxygen
(𝑇 = −1) to heliox (𝑇 = 0), respiratory settings needed
adjustment according to the study protocol with limited tidal
volume ventilation. Minute volume ventilation slightly rose
after switching from oxygen to heliox, but no significant
difference was found between before and right after the
start of heliox ventilation (Figure 1).Thereafter, during heliox
ventilation, respiratory rates were adjusted to targeted pH
and PaCO
2
levels, in accordance with the study protocol.
This resulted in a significant decrease in respiratory rate
and tended to decrease minute volume ventilation (Figure 1).
After discontinuation of helium these parameters did not
change. Tidal volumes remained stable at 6mL/kg according
to study and standard ICU protocol and did not change over
time (data not shown). Peak pressures tended to decrease,
albeit in a nonsignificant manner (Figure 1). Airway resis-
tance and dynamic lung compliance by the ventilator did not
change during heliox ventilation (Figure 1).
Switch from oxygen in air to heliox ventilation resulted
in a rapid decrease in PaCO
2
levels, which increased again at
discontinuation of heliox (Figure 2). PaCO
2
levels showed no
changes during the 3 hours of heliox ventilation (Figure 2).
Also, an increase in pH to 7.37 was seen shortly after the
application of heliox ventilation (Figure 2). In the course of
Critical Care Research and Practice 3

















































































































































Figure 1: Respiratory parameters during heliox ventilation for 3 hours (𝑇 = 0 to 𝑇 = 3) and after switch to normal oxygen in air mixture
(𝑇3 to 𝑇6). Measurements started prior to heliox administration (𝑇 = −1). Data are means ± SEM. (a) Minute volume ventilation (Lmin−1);






gradient (mmHg); (e) airway resistance (cmH
2
O
mL−1 sec−1); and (f) lung compliance (mL cm−1 H
2
O). ∗: 𝑃 < 0.02.
heliox ventilation, pH tended to increase further but showed
no change after discontinuation of heliox. Oxygenation was
not altered significantly after the start of heliox or after
switching back to oxygen (Figure 2). Applied FiO
2
levels





In adult patients ventilated with protective mechanical ven-
tilation strategy according to current ventilation guidelines
[8], the use of heliox improved ventilation, by allowing lower
minute volume ventilation while PaCO
2
levels decreased.
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Figure 2: Gas exchange during ventilation with heliox for 3 hours (𝑇 = 0 to 𝑇 = 3). Measurements started just prior to heliox administration
(𝑇 = −1) until 3 hours after heliox discontinuation (𝑇 = 3 to𝑇 = 6). Data aremeans± SEM. (a) PaCO
2
(kPa); (b) end tidal CO
2
measurements




ratio (mmHg). ∗: 𝑃 < 0.02; ∗∗: 𝑃 < 0.01; ∗ ∗ ∗: 𝑃 < 0.001.
The use of heliox ventilation has beenmostly investigated
in respiratory conditions such as upper-airway obstruction,
asthma, bronchiolitis, and croup. Results indicate that heliox
improves gas exchange and reduces work of breathing [4–
6]. Most of the studies were performed in the pediatric
population. In this study we focused on adult patients.
Cardiac arrest patients are obviously not the patients who are
expected to benefitmost from loweringminute volume venti-
lation, because these patients do not have obstructed airflow.
Nevertheless this population was studied, since the feasibility
study investigating neuroprotective properties of heliox [7]
enabled us to investigate the response to heliox ventilation in
adult patients ventilated with pressure controlled ventilation
modes and currently recommended protective settings. The
reduction of respiratory ratewith the concomitant decrease of
peak pressures during heliox ventilation is promising result.
Given that changes were small, it can, however, be questioned
whether these results have clinical relevance. Effects of heliox
may have been mild because baseline resistance as well as
compliance in these patients without lung injury was not
severely hampered. It remains to be determined whether
heliox is beneficial in patients with respiratory failure in
whomprotective ventilation is hampered by the development
of respiratory acidosis.
Our study has several limitations. As this study was a
secondary analysis of a safety and feasibility study on the use
of heliox in cardiac arrest patients, the number of patients was
not primarily powered to investigate the effects of heliox on
ventilation. This may explain observed trends but absence of
statistical significance. Also, no control group was present.
Thereby, the influence of time on findings is unknown.
However, our data clearly show an increased CO
2
removal
and improved ventilation, starting immediately after start of
heliox ventilation. Long-term effects could not be studied as
heliox ventilation was limited to 3 hours. Another limitation
may be that all patients received therapeutic hypothermia,
which is known to decrease PaCO
2
levels [9]. However,
throughout the whole study period, temperatures were in
the range of therapeutic induced hypothermia. Thereby,
observed effects could not be due to hypothermia.
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5. Conclusions
Heliox ventilation improved CO
2
elimination and allowed
for, though nonsignificant, decrease in minute volume venti-
lation, in a selected group of patients ventilated in a pressure
controlled mode according to the guidelines of the ARDS
network [8]. Results may generate new hypotheses for future
research considering heliox as a therapeutic possibility in
patientswhose protectivemechanical ventilation is hampered
by the development of respiratory acidosis.
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